• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sandu Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4291.0
  • ISIN : INE751D01014
46.85 -3 (-5.33%)
  • As on 26 Jul 2025 (EOD)

  • Today’s Low

    45.36

  • Today’s High

    49.00

  • Open

    49.00

  • Perv Close

    49.49

  • 52W Low

    43.75

  • 52W High

    69.50

Key Indicators

  • P/E(TTM)

    29.28

  • Mar.Cap (₹Cr.)

    45.26

  • Div & Yield %

    0.00

  • Book Value(₹)

    43.50

  • Debt-Equity Ratio

    -5.33

  • AGM Date

    25-Jul-2025

  • EPS

    1.60

  • P/E Ratio

    29.28

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    45.26

  • RONW (%)

    3.66

  • ROCE (%)

    5.33

Score Board

  • Equity (₹ in Cr.)

    9.66

  • BV (₹)

    43.50

  • Sales( ₹ in Cr.)

    67.19

  • NP (in Cr.)

    1.55

  • NP Var(%)

    6.0

  • Div%

    0.0

  • CPS (₹)

    2.30

  • EPS (₹)

    1.60

  • Traded Value (₹ in Lakhs)

    45.26

  • 52 Week High

    69.50

  • 52 Week Low

    43.75

  • Price BSE

    47.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    45.26

  • P/C Ratio

    20.50

  • P/E Ratio

    29.30

  • Price Vs.BV

    1.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 67.28 65.35 65.50 58.76 48.37 49.42
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 67.28 65.35 65.50 58.76 48.37 49.42
Other Income 0.42 0.33 0.08 0.19 0.45 0.57
Stock Adjustments -1.63 3.08 0.45 -3.39 1.03 1.57
Total Income 66.07 68.76 66.03 55.56 49.85 51.56
EXPENDITURE :            
Raw Materials 30.94 34.27 36.20 31.11 26.15 26.91
Power and Fuel Cost 0.41 0.39 0.34 0.33 0.33 0.33
Employee Cost 10.07 11.10 8.91 8.02 6.85 6.49
Other Manufacturing Expenses 6.35 6.19 5.98 5.21 4.22 4.03
Selling and Administration Expenses 15.24 13.75 11.45 8.31 10.28 10.79
Miscellaneous Expenses 0.34 0.25 0.19 0.24 0.12 0.36
Employee Benefit Expenses 10.07 11.10 8.91 8.02 6.85 6.49
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 63.35 65.94 63.08 53.21 47.95 48.90
Operating Profit 2.72 2.82 2.96 2.35 1.90 2.66
Interest 0.06 0.08 0.11 0.11 0.43 1.01
Gross Profit 2.66 2.74 2.85 2.24 1.47 1.65
Depreciation 0.58 0.52 0.53 0.56 0.55 0.64
Profit Before Tax 2.08 2.22 2.32 1.68 0.92 1.01
Current Tax 0.59 0.66 0.70 0.56 0.13 0.37
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.02 0.03 0.03 0.03 0.07 -0.02
Reported Net Profit 1.46 1.52 1.59 1.09 0.72 0.67
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 1.46 1.52 1.59 1.09 0.72 0.67
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 7.70 6.68 4.97 3.27 2.41 1.61
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.57 0.51 -0.11 -0.61 -0.14 -0.14
P & L Balance carried down 8.59 7.70 6.68 4.97 3.27 2.41
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 8.00 0.00 7.50 5.00 0.00 0.00
Dividend Per Share(Rs) 0.80 0.00 0.75 0.50 0.00 0.00
Earnings Per Share-Unit Curr 1.51 1.58 1.80 1.38 1.02 0.94
Earnings Per Share(Adj)-Unit Curr 1.51 1.58 1.80 1.38 1.02 0.94
Book Value 42.02 40.62 30.71 29.63 28.22 40.66
Book Value(Adj)-Unit Curr 42.02 40.62 30.71 29.63 28.22 40.66

Shareholding Pattern

  • Promoter Group

    42.90%

  • Public Share Holding

    57.10%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,650,548 37.79 3,650,548 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 494,182 5.12 494,182 1
Sub Total 4,144,730 42.90 4,144,730 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 500 0.01 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 500 0.01 0 1
2] Non Institution
Bodies Corporate 1,760,969 18.23 1,752,069 50
Clearing Members 660 0.01 660 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 53,604 0.55 53,604 31
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 134,131 1.39 133,831 100
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 747,055 7.73 747,055 9
Individuals holding nominal share capital up to Rs. 1 lakh 2,785,490 28.83 2,001,240 10,015
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,100 0.01 1,100 2
Others 8,100 0.08 5,600 3
Sub Total 5,515,760 57.09 4,719,810 10,218
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 9,660,990 100.00 8,864,540 10,226

Company Background

Sandu Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Sandu Pharmaceuticals Ltd
  • BSE Code : 4291.0
  • ISIN : INE751D01014

  • Incorporation Year

    1985

  • Registered Office

    Plot No 25/26/29 & 30
    Pilerne Indl Estate Marra Bard, Bardez,
    Goa-403511

  • Telephone

  • FAX

  • Chairman

    Balaram Vishwanathan

  • Managing Director

    Umesh B Sandu

  • Company Secretary

    Pratika Mhambray

  • Auditor

    Dileep & Prithvi

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Sharex Dynamic (India) Pvt Ltd
    C-101 247 Park ,
    L B S Marg ,Vikhroli West
    Mumbai - Mumbai - 400083

Sandu Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sandu Pharma. 46.85 67.70 67.28 29.28 5.33
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10